Author Archives: admin

Infliximab Now Approved for Self Injection in Rheumatoid Arthritis

Infliximab was launched by Janssen over 20 years ago under the name Remicade.  It continues to be a biologic therapy given by infusion (IV) for many autoimmune conditions including rheumatoid arthritis, ankylosing spondylitis, psoriasis, Crohn’s, and ulcerative colitis.  In the … Continue reading

Posted in The Charlton Center | Leave a comment

Second Dose Imperative For Protection in Compromised Patients

We are all aware of the importance of completing both doses of Covid-19 vaccines to get the best protection.  In light of new variants, the push is on to get second doses as soon as possible.  A recent independent study … Continue reading

Posted in The Charlton Center | Leave a comment

Second Covid-19 Vaccine Dose Eligibility

It is very exciting to share the news that many of you with high-risk health conditions, will be eligible to receive your second dose at an earlier time. Check with your local health department about the opportunity to have your … Continue reading

Posted in The Charlton Center | Leave a comment

Eat Smart for Arthritis

Charlton Health is always on the lookout for great educational resources to share with our patients. We love sharing the work that the Arthritis Society does as their programming is abundant and readily accessible. Tonight the Arthritis Society is hosting … Continue reading

Posted in The Charlton Center | Leave a comment

COVID-19 Vaccination Weekly Forum

This week we are happy to share a great learning opportunity. COVID Discussions is a weekly meeting where a group of Canadian health professionals with expertise in vaccination offer weekly information sessions to answer questions from both the public and … Continue reading

Posted in The Charlton Center | Leave a comment

Can we measure TNF (Tumour Necrosis Factor)?

Recently I was asked if a person’s TNF level could be measured to know if a biologic that lowers TNF is a good treatment for them. I wish it was that easy! Although we can do blood tests for markers of … Continue reading

Posted in The Charlton Center | Leave a comment

COVID-19 Vaccination Phase 2 Includes Compromised Patients

In writing this blog, we are all aware that the vaccine distribution continues to be updated.  Phase 2 of vaccine distribution is to include patients who have compromising conditions or treatments that suppress the immune system,  regardless of the person’s … Continue reading

Posted in The Charlton Center | Leave a comment

First Canadian dose of Biosimilar Adalimumab (Amgevita) administered at Charlton Health!

Charlton Health is proud to announce that the first dose in Canada of the biosimilar adalimumab, known as Amgevita (produced by Amgen), was injected at Charlton Health on February 22, 2021. Five biosimilars of adalimumab were released onto the Canadian market … Continue reading

Posted in The Charlton Center | Leave a comment

American College of Rheumatology Announces COVID-19 Clinical Guidance Summary

The American College of Rheumatology (ACR) is a prominent organization that provides expert guidance on the diagnosis and treatment of rheumatic conditions.  Their annual meeting has over 15,000 clinicians from around the world in attendance. This week they held a town … Continue reading

Posted in The Charlton Center | Leave a comment

COVID-19 Patient Decision Aid from the Canadian Rheumatology Association and CAPA (Canadian Arthritis Patience Alliance)

Since our last blog providing guidance for the COVID-19 vaccine, we have had many calls asking if patients on disease modifying treatments, such as biologic therapies, methotrexate, leflunomide etc. should hold their dose after getting the COVID-19 vaccine for a … Continue reading

Posted in The Charlton Center | Leave a comment